Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 16Myelodysplastic Syndromes 3Leukemia, Monocytic, Acute 3Leukemia 3Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphoid 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Disease 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

Cytarabine 23fludarabine phosphate 9Daunorubicin 9Mitoxantrone 8Busulfan 8Peripheral Blood Stem Cell Transplantation 6Methotrexate 6Idarubicin 6Gemtuzumab 6Etoposide 6Whole-Body Irradiation 5Filgrastim 5Cyclophosphamide 5Clofarabine 5tipifarnib 4alvocidib 4Vorinostat 4Tacrolimus 4Cyclosporine 4Azacitidine 4Antilymphocyte Serum 4sargramostim 3Observation 3Mycophenolic Acid 3Flow Cytometry 3Decitabine 3Cytogenetic Analysis 3Bortezomib 3fludarabine 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Erythroblastic, Acute × CPX-351 × Clear all
NCT02019069 2019-01-22

CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Stanford University

Phase 2 Completed
11 enrolled 17 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡